Invariant NKT and NKT-like lymphocytes: Two different T cell subsets that are differentially affected by ageing

被引:84
作者
Peralbo, Esther [1 ]
Alonso, Corona [1 ]
Solana, Rafael [1 ]
机构
[1] Univ Cordoba, Reina Sofia Univ Hosp, Fac Med, Dept Immunol, E-14004 Cordoba, Spain
关键词
NKT cells; NKT-like cells; v alpha 24; CD1d; CD56; glycolipids;
D O I
10.1016/j.exger.2007.05.002
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The expression on T lymphocytes of surface receptors that are characteristically expressed on NK cells has led to the definition of a T cell subset that has been termed Natural Killer T (NKT) cells. Thus NKT cells constitute a minor lymphocyte population that exhibits features of both T cells and NK cells. However, the term 'NKT cell' has been applied variably to cells that express a restricted T-cell receptor (TCR) that recognizes glycolipids (alpha-GalCer) presented by the MHC-like molecule CD1d and that express CD161, as well as populations of conventional CD8 T cells that show up-regulated expression of NK-cell markers. The CDld restricted T cells have a semi-invariant TCR using the V alpha 24J alpha 18 genes in humans (V alpha 24J alpha 18 in mice) and are denominated invariant NKT (iNKT) cells. On the other hand mainstream T cells that express NK associated receptors (NKR) show a highly specialized effector memory phenotype and are frequently referred as NKT-like cells. These T lymphocyte subsets are differentially affected by ageing. Whereas human peripheral blood iNKT cells decrease with age, there is an increase in the percentage of peripheral blood NKT-like T lymphocytes. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:703 / 708
页数:6
相关论文
共 76 条
  • [1] Diversity of NKR expression in aging T cells and in T cells of the aged: The new frontier into the exploration of protective immunity in the elderly
    Abedin, S
    Michel, JJ
    Lemster, B
    Vallejo, AN
    [J]. EXPERIMENTAL GERONTOLOGY, 2005, 40 (07) : 537 - 548
  • [2] Cutting edge: Lectin-like transcript 1 is a ligand for the CD161 receptor
    Aldemir, H
    Prod'homme, V
    Dumaurier, MJ
    Retiere, C
    Poupon, G
    Cazareth, J
    Bih, F
    Braud, VM
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (12) : 7791 - 7795
  • [3] Oligoclonality of CD8+ T cells in health and disease: Aging, infection, or immune regulation?
    Batliwalla, F
    Monteiro, J
    Serrano, D
    Gregersen, PK
    [J]. HUMAN IMMUNOLOGY, 1996, 48 (1-2) : 68 - 76
  • [4] Characterization of the early stages of thymic NKT cell development
    Benlagha, K
    Wei, DG
    Veiga, J
    Teyton, L
    Bendelac, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (04) : 485 - 492
  • [5] Working with NKT cells - pitfalls and practicalities
    Berzins, SP
    Smyth, MJ
    Godfrey, DI
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (04) : 448 - 454
  • [6] Parallels and distinctions between T and NKT cell development in the thymus
    Berzins, SP
    Uldrich, AP
    Pellicci, DG
    McNab, F
    Hayakawa, Y
    Smyth, MJ
    Godfrey, DI
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (03) : 269 - 275
  • [7] NK phenotypic markers and IL2 response in NK cells from elderly people
    Borrego, F
    Alonso, MC
    Galiani, MD
    Carracedo, J
    Ramirez, R
    Ostos, B
    Peña, J
    Solana, R
    [J]. EXPERIMENTAL GERONTOLOGY, 1999, 34 (02) : 253 - 265
  • [8] Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells
    Borrego, F
    Kabat, J
    Kim, DK
    Lieto, L
    Maasho, K
    Peña, J
    Solana, R
    Coligan, JE
    [J]. MOLECULAR IMMUNOLOGY, 2002, 38 (09) : 637 - 660
  • [9] CD1: Antigen presentation and T cell function
    Brigl, M
    Brenner, MB
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 : 817 - 890
  • [10] CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype
    Casado, JG
    Soto, R
    DelaRosa, O
    Peralbo, E
    Muñoz-Villanueva, MD
    Rioja, L
    Peña, J
    Solana, R
    Tarazona, R
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (12) : 1162 - 1171